Skip to main content
. 2016 May 21;17(5):790. doi: 10.3390/ijms17050790

Figure 1.

Figure 1

PD-L1 (programmed death ligand 1) staining: (A) Anti-PD-L1 (SP-142) clone in placenta sample (40×); and (B) Anti-PD-L1 (SP-142) clone in tumor sample (40×) with a detail of cell membrane positivity (60×).